Eduard M. V.
- Country
- Spain
- Department
- NA
Research Overview
- A study evaluating the safety and efficacy of once-weekly dosing of somapacitan in a basket study design in paediatric participants with short stature either born small of gestational age or with Turner syndrome, Noonan syndrome or idiopathic short stature
- Efficacy and Safety of Cagrilintide Monotherapy and Cagrilintide plus Semaglutide for Weight Management in Children and Adolescents with Overweight or Obesity
Data & Insights
Has run more than one trial at 3 of 41 partner sites.
Specializations
Growth Disorders
The investigator specializes in pediatric growth disorders, with particular focus on growth hormone therapy in children with various growth-related conditions.
- Small for gestational age (SGA) management
- Idiopathic short stature (ISS) treatment
- Turner's syndrome growth optimization
- Noonan syndrome therapeutic approaches
The investigator's work centers on evaluating innovative therapeutic options for pediatric patients requiring growth intervention.
Pediatric Endocrinology
The investigator focuses on advancing treatment methodologies in pediatric endocrinology, particularly examining weekly administration protocols for growth disorders.
- Long-acting growth hormone treatments
- Pediatric growth optimization
- Endocrine disorder management
- Growth trajectory monitoring
Their research encompasses both treatment-naïve and previously treated pediatric populations.
Clinical Development
The investigator's work involves evaluating therapeutic safety and efficacy in pediatric populations with various growth disorders.
- Safety assessment protocols
- Growth response evaluation
- Treatment optimization strategies
- Long-term outcome assessment
Their research aims to establish comprehensive safety profiles for growth hormone treatments in diverse pediatric populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.